ENO1 Antikörper
Kurzübersicht für ENO1 Antikörper (ABIN7384339)
Target
Alle ENO1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Affinity Purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:1000 IHC 1:100-1:200 IF 1:50-1:100
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 300 μg/mL
-
Buffer
- 50 mM Tris-Glycine( pH 7.4), 0.15M NaCl, 40 % Glycerol, 0.01 % Sodium azide and 0.05 % BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ENO1 (Enolase 1 (ENO1))
-
Andere Bezeichnung
- ENO1
-
Hintergrund
- 2 phospho D glycerate hydro lyase,2-phospho-D-glycerate hydro-lyase,Alpha enolase,Alpha enolase like 1,Alpha-enolase,C myc promoter binding protein,C-myc promoter-binding protein,EC 4.2.1.11,eno1,ENO1L1,ENOA,Enolase 1 (alpha),Enolase 1 (alpha) like 1,Enolase 1,Enolase alpha,MBP 1,MBP-1,MBP1,MBPB1,MPB 1,MPB-1,MPB1,MYC promoter binding protein 1,NNE,Non neural enolase,Non-neural enolase,Phosphopyruvate hydratase,Plasminogen binding protein,Plasminogen-binding protein,PPH,Tau crystallin,Enolase is an important glycolytic enzyme involved in the interconversion of 2-phosphoglycerate to phosphoenolpyruvate.Enolase were down-regulated in oxLDL-treated cells or in VLDL-treated cells .And it identified which are associated with glucose metabolism were down-regulated in the process of foam cells formation.
-
Molekulargewicht
-
Observed_MW: 47kDa
Calculated_MW: 47kDa
-
Gen-ID
- 2023
-
UniProt
- P06733
Target
-